Getting your player ready...
TRENTON, N.J. — Global sales of vaccines grew by a healthy 16 percent last year, when sales shot up to $22.1 billion, health care market research publisher Kalorama Information reported Friday.
Its researchers forecast vaccine sales will rise at a compound annual rate of 9.7 percent during the next five years, fueled by wider use of current vaccines and introduction of new ones. That would push sales to roughly $35 billion. Sales in 2008 were barely half as much, at $19 billion.
Vaccines are a priority research area for several major pharmaceutical companies, including the top two vaccine makers, Merck & Co. and GlaxoSmithKline PLC. The Associated Press
